CLINICAL_TRIALS ClinicalTrials.gov record update

Possible Role of Inflammatory Serum Biomarkers in Differentiation Between Epileptic Seizure and Psychogenic Non-epileptic Seizure

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT05571371
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:38:57.419010+00:00
Published At: 2022-10-07T00:00:00+00:00
Record Updated At: 2022-10-07
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Localization-Related (Focal) (Partial) Idiopathic Epilepsy and Epileptic Syndromes With Seizures of Localized Onset", "TRAIL: Tumor Necrosis Factor Related Apoptosis Inducing Ligand MCP-2", "MCP-2: Monocyte Chemo-attractant Protein-2"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2022-10-07"
protocolSection.identificationModule.nctId: "NCT05571371"
protocolSection.identificationModule.officialTitle: "Possible Role of Inflammatory Serum Biomarkers in Differentiation Between Epileptic Seizure and Psychogenic Non-epileptic Seizure"
protocolSection.statusModule.overallStatus: "UNKNOWN"
protocolSection.designModule.phases: []
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.